Screening and detection of carbapenemases

Similar documents
Insert for Kit 98006/98010/ KPC/Metallo-B-Lactamase Confirm Kit KPC+MBL detection Kit KPC/MBL and OXA-48 Confirm Kit REVISION: DBV0034J

Sensitive and specific Modified Hodge Test for KPC and metallo-beta-lactamase

Detecting carbapenemases in Enterobacteriaceae

Discussion points CLSI M100 S19 Update. #1 format of tables has changed. #2 non susceptible category

Received 31 January 2011/Returned for modification 2 March 2011/Accepted 15 March 2011

NONFERMENTING GRAM NEGATIVE RODS. April Abbott Deaconess Health System Evansville, IN

Detecting CRE. what does one need to do?

Phenotypic detection of ESBLs and carbapenemases

Detection of Carbapenem Resistant Enterobacteriacae from Clinical Isolates

Original Article Clinical Microbiology

In-House Standardization of Carba NP Test for Carbapenemase Detection in Gram Negative Bacteria

Educational Workshops 2016

Carbapenem Disks on MacConkey agar as screening methods for the detection of. Carbapenem-Resistant Gram negative rods in stools.

Detection of resistance mechanisms using Neo- Sensitabs and Diatabs. Detection of beta lactamases. Carbapenemases and phenotypic methods for detection

MHSAL Guidelines for the Prevention and Control of Antimicrobial Resistant Organisms (AROs) - Response to Questions

Carbapenems and Enterobacteriaceae

Combined disk methods for the detection of KPC- and/or VIM-positive. Klebsiella pneumoniae: improving reliability for the double carbapenemase

Evaluation of CHROMagar msupercarba for the detection of carbapenemaseproducing Gram-negative organisms

Phenotypic Detection Methods of Carbapenemase Production in Enterobacteriaceae

Carbapenemases in Enterobacteriaceae: Prof P. Nordmann Bicêtre hospital, South-Paris Med School

Methodological and interpretative problems in antimicrobial susceptiblity tests of P. aeruginosa

Carbapenemase-producing Enterobacteriaceae

Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011

Detecting Carbapenemase-Producing Enterobacteriaceae: why isn t there a single best method?

Nature and Science 2017;15(10)

ORIGINAL ARTICLE. Julie Creighton and Clare Tibbs. Canterbury Health Laboratories, Christchurch

Differentiation of Carbapenemase producing Enterobacteriaceae by Triple disc Test

#Corresponding author: Pathology Department, Singapore General Hospital, 20 College. Road, Academia, Level 7, Diagnostics Tower, , Singapore

CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE

Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories

Supplementary Material Hofko M et al., Detection of carbapenemases by real-time PCR and melt-curve analysis on the BD MAX TM System

Detection of resistance mechanisms using Neo- Sensitabs and Diatabs

Evaluation of Six Phenotypic Methods for the Detection of Carbapenemases in Gram-Negative Bacteria With Characterized Resistance Mechanisms

New Mechanisms of Antimicrobial Resistance and Methods for Carbapenemase Detection

Rapid detection of carbapenemase-producing Pseudomonas spp.

Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae

Detection of SPM-1-producing Pseudomonas aeruginosa and CHDL-producing. Acinetobacter baumannii using Liquid Chromatography Mass Spectrometry

Use of Faropenem as an Indicator of Carbapenemase Activity

Laboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator

Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital

(Plasmid mediated) Carbapenemases. Timothy R. Walsh, Cardiff University, Wales

ALERT. Clinical microbiology considerations related to the emergence of. New Delhi metallo beta lactamases (NDM 1) and Klebsiella

Update on CLSI and EUCAST

Standardisation of testing for Carbapenemase Producing Organisms (CPO) in Scotland

Determining the Optimal Carbapenem MIC that Distinguishes Carbapenemase-Producing

North Carolina CRE Laboratory Task Force

Revised AAC Version 2» New-Data Letter to the Editor ACCEPTED. Plasmid-Mediated Carbapenem-Hydrolyzing β-lactamase KPC-2 in

Development of a phenotypic method for fecal carriage detection of OXA-48-producing

2612 Page. *Yusuf, I 1., Rabiu A.T 1., Haruna, M 2. and Abdullahi, S. A 3. Phone:

β CARBA Test Rapid detection of carbapenemase-producing Enterobacteriaceae strains Contents 1. INTENDED USE

EVALUATION OF METHODS FOR AMPC β-lactamase IN GRAM NEGATIVE CLINICAL ISOLATES FROM TERTIARY CARE HOSPITALS

Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia

Rapid identification of emerging resistance in Gram negatives. Prof. Patrice Nordmann

Incidence of metallo beta lactamase producing Pseudomonas aeruginosa in ICU patients

Methods for colistin testing What works and what does not? Erika Matuschek, Ph D EUCAST Development Laboratory, EDL

Scottish Microbiology and Virology Network. Carbapenemase producers: screening and the new Scottish AMR Satellite Reference Laboratory Service

β-lactamase inhibitors

ARTICLE IN PRESS International Journal of Antimicrobial Agents xxx (2010) xxx xxx

Identification and screening of carbapenemase-producing Enterobacteriaceae

Carbapenemases: A Review

K. Lee, Y. S. Lim, D. Yong, J. H. Yum, and Y. Chong*

SUPPLEMENTAL TESTING. Tan Thean Yen

Academic Perspective in. David Livermore Prof of Medical Microbiology, UEA Lead on Antibiotic resistance PHE

Results and experience of BARN ESBL project. Marina Ivanova and project team Tallinn

Laboratory testing for carbapenems resistant Enterobacteriacae (CRE)

Journal of Infectious Diseases and

AAC Accepts, published online ahead of print on 13 October 2008 Antimicrob. Agents Chemother. doi: /aac

Abstract. Introduction. Editor: R. Canton

β- Lactamase Gene carrying Klebsiella pneumoniae and its Clinical Implication

Comparison of phenotypic methods for the detection of carbapenem non-susceptible Enterobacteriaceae

Toolkit for the Management of Carbapenemase Producing Organisms (CPO)

Emergence of non-kpc carbapenemases: NDM and more

Controversial Issues in Susceptibility Testing: Point/Counterpoint. April N. Abbott, PhD D(ABMM) Romney M. Humphries, PhD D(ABMM)

False susceptibility of antibitoics to carbapenemase producers and means to overcome

SSRG International Journal of Medical Science (SSRG-IJMS) volume 2 Issue 4 April 2015

Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by MALDI- TOF mass spectrometry

Activity of tigecycline alone and in combination with colistin and meropenem against carbapenemase

AST issues of polymyxins and their implications for the routine laboratory

EUCAST Frequently Asked Questions. by author. Rafael Cantón Hospital Universitario Ramón y Cajal, Madrid, Spain EUCAST Clinical Data Coordinator

Why some tests are no longer recommended

Disclosure. Objectives. Evolution of β Lactamases. Extended Spectrum β Lactamases: The New Normal. Prevalence of ESBL Mystic Program

Clinical Microbiology Newsletter

COMMENTARY. Extended-Spectrum- -Lactamase, AmpC, and Carbapenemase Issues. Kenneth S. Thomson*

Multidrug-resistant organisms are a major public health

Recommendations for the Management of Carbapenem- Resistant Enterobacteriaceae (CRE) in Acute and Long-term Acute Care Hospitals

Rapid detection of carbapenemase-producing Enterobacteriaceae from blood cultures

Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues

In Vitro Activity of Ceftazidime-Avibactam Against Isolates. in a Phase 3 Open-label Clinical Trial for Complicated

Fernando Pasteran, Tania Mendez, Melina Rapoport, Leonor Guerriero, and Alejandra Corso*

Risk factors for fecal carriage of carbapenemase producing Enterobacteriaceae among intensive care unit patients from a tertiary care center in India

International Journal of Current Microbiology and Applied Sciences ISSN: Volume 7 Number 01 (2018) Journal homepage:

Expert rules. for Gram-negatives

Reporting blood culture results to clinicians: MIC, resistance mechanisms, both?

Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test

Enterobacteriaceae with acquired carbapenemases, 2016

ST11 KPC-2 Klebsiella pneumoniae detected in Taiwan

Faecal carriage of ESBL-producing Enterobacteriaceae and carbapenemresistant Gram-negative bacilli in community settings

suspected KPC and other carbapenemase producers among species of Nacional de Enfermedades Infecciosas (INEI)- ANLIS Dr. Carlos G.

Multicenter study of the prevalence and the resistance mechanisms of carbapenem-resistant Enterobacteriaceae (CPE) in Belgium in

Transcription:

Screening and detection of carbapenemases For many isolates with carbapenemases the MICs of carbapenems are around the susceptible breakpoint making resistance difficult to detect - particularly with automated systems. Therefore special zone breakpoints are needed in first line screening Strains with reduced susceptibility to Imipenem, Meropenem (both inhibition zone < 22 mm) or Ertapenem (zone < 21mm) on Mueller-Hinton Agar with McFarland 0.5 inoculum, should be suspected of possessing carbapenemases. Most isolates with KPC and GES enzymes are highly resistant to Ceftazidime. Ertapenem Neo-Sensitabs is the most sensitive indicator for possible carbapenemase, but in approximately 20 % of cases other resistance mechanisms are involved (confirmation of carbapenemase with Modified Hodge Test is necessary). It is important to recognize small resistant colonies growing inside the Ertapenem disk zone.

A) PROCEDURE FOR METALLO BETA LACTAMASE (MBL) DETECTION. ENTEROBACTERIACEAE Apply one Dipicolinic Acid Diatabs (DPA) on an inoculated Mueller Hinton (MH) plate. Apply one Meropenem Neo-Sensitabs and one Ertapenem Neo-Sensitabs onto the plate on either side of the DPA, 5mm from the DPA (edge to edge). Apply Imipenem + EDTA (IM+ED) on an inoculated MH plate. Apply one Meropenem Neo-Sensitabs and one Ertapenem Neo-Sensitabs at either side of the Imipenem + EDTA, 10 mm from the Imipenem + EDTA (edge to edge). NON FERMENTERS Apply one DPA Diatabs on the MH plate. Apply one Imipenem Neo-Sensitabs and one Meropenem Neo-Sensitabs at either side of the DPA, 5 mm from the DPA (edge to edge). Apply Imipenem + EDTA (IM+ED) on the inoculated MH plate. Apply one Meropenem Neo Sensitabs and one Ertapenem Neo-Sensitabs at either side of the Imipenem + EDTA, 10 mm from the Imipenem + EDTA (edge to edge). INTERPRETATION The use of two chelating agents EDTA and DPA will enhance the detection of metallo ß lactamases (MBL) in the clinical laboratory. A key hole or ghost zone between carbapenems (one or more) and Dipicolinic Acid indicates the presence of an MBL. A key hole or ghost zone between IM+ED and the carbapenems (one or more) indicates the prescence of an MBL. A key hole or ghost zone between carbapenems (one or more) and Dipicolinic Acid indicates the presence of a MBL. Please note: Most MH agar brands contain physiological levels of Zn ++ ions and should be used for carbapenem testing. Iso Sensitest agar has low levels of zinc ions and may give false susceptibility results for carbapenems in the presence of MBL. Some MH agar brands should also be supplemented with zinc ions (70 mg zinc sulphate. H 2 O per liter medium). This applies also to the Modified Hodge Test (MHT). Strains of Acinetobacter baumannii producing certain oxacillinases may give a false positive metallo-ß-lactamase test result. Screening and detection of carbapenemases version C 03.2009 Page 2

B) PROCEDURE FOR KPC CARBAPENEMASES DETECTION (CLASS A ENZYMES) Isolates giving negative metallo beta lactamase tests, may produce other carbapenemases. The most current are KPC enzymes isolated from Enterobacteriaceae (K. pneumoniae, E. coli, Enterobacter spp., P. mirabilis) particularly K. pneumoniae. To detect these strains in rectal swab screening samples, direct plating on McConkey agar in the presence of Ertapenem Neo Sensitabs and Imipenem Neo Sensitabs may be used. Place one Amoxycillin + Clavulanate Neo Sensitabs between one Ertapenem and one Imipenem Neo Sensitabs (distance 10 mm from edge to edge). Place one Boronic Acid Diatabs between one Ertapenem and one Imipenem Neo Sensitabs (distance mm from edge to edge). Perform Modified Hodge Test (MHT) with Ertapenem and Meropenem Neo Sensitabs. INTERPRETATION The following results will presumably indicate the presence of a KPC beta lactamase: a) Negative metallo beta lactamases tests. b) Positive synergy test between Boronic Acid and the carbapenems (one or both). c) Negative synergy test between Cloxacillin 500 μg and the carbapenems (11). d) Positive synergy test between clavulanate (AMC) and carbapenems (one or both). Not always easy to see. Although isolates with ESBL + impermeability will give false positive results. e) Positive Modified Hodge Test. Please notice: Test only ertapenem resistant strains. Ertapenem susceptible strains may provide a false positive result with Boronic Acid. Conclusion: Reduced susceptibility to ertapenem, synergy between Boronic Acid and the carbapenems, and no synergy between Cloxacillin 500 g and the carbapenems is clearly indicative of KPC enzyme being present. Isolates producing high level AmpC + impermeability can be detected by synergy between Cloxacillin 500 μg and the carbapenems (11). Screening and detection of carbapenemases version C 03.2009 Page 3

C) PROCEDURE FOR OXACILLINASE DETECTION (CLASS D ENZYMES) Strains producing oxacillinases will currently show zones of inhibition < 21 mm with Ertapenem and/or <23 mm with Meropenem Neo Sensitabs. Most are resistant to Aztreonam. These enzymes are mainly found in Acinetobacter baumannii but also in Enterobacteriaceae (K. pneumoniae, Enterobacter) and P. aeruginosa although these are rare. INTERPRETATION The following results will presumably indicate the presence of oxacillinases: a) Negative metallo beta lactamase tests. b) Negative (or weak positive) synergy test between clavulanate (AMC) and carbapenems (one or both). c) Positive Modified Hodge Test. (Addition of zinc ions: 70 mg zinc sulphate.h20 /liter medium may be necessary to detect oxacillinases). An isolate is counted positive when it fulfils the 3 criteria. 10 10 MER IM+ED ERT BOR BOR 5 5 10 AMC DPA MER ERT CLOX CLOX 10 AMC Screening of carbapenemases IM+ED = Imipenem + EDTA Neo S, MER = Meropenem Neo S, ERT = Ertapenem Neo S, DPA = Dipicolinic Acid Diatabs, AMC = Amoxycillin+Clavulanate Neo S. CLOX = Cloxacillin 500 μg Diatabs With non fermenters use Imipenem Neo S instead of Ertapenem Neo S. Screening and detection of carbapenemases version C 03.2009 Page 4

MODIFIED HODGE TEST (MHT) Is used to determine if resistance to carbapenems is caused by a carbapenemase. A MH agar plate (or a McConkey plate) is inoculated with the susceptible strain E. coli ATCC 25922 (Mc Farland 0.5, diluted 1/10) as for disk diffusion. When testing Enterobacteriaceae, one Ertapenem Neo Sensitabs and one Meropenem Neo Sensitabs are applied onto the plate approx. 30 mm apart from each other. For non fermenters one Imipenem Neo Sensitabs and one Meropenem Neo Sensitabs are applied. A suspension of the microorganism to be tested for carbapenemase is adjusted to Mc Farland 0.5 standard and a loop is used to make a streak passing through the two carbapenem disks. Two more streaks are placed perpendicularly making a cross. Thereafter incubation for 18 24 hours at 35 37 C. Alteration in the shape (indentation) of the zones of inhibition around the test organism is considered indicitive of the presence of a carbapenemase (figure). Ertapenem Meropenem K. pneumoniae KPC positive Modified Hodge Test (MHT) With non fermenters use Imipenem Neo S instead of Ertapenem. Screening and detection of carbapenemases version C 03.2009 Page 5

PRODUCTS MENTIONED IN THE BROCHURE INCLUDING REF NO: DIATABS Product code Diatabs 10041 Boronic Acid 10051 Dipicolinic Acid 10031 Cloxacillin 500 μg NEO SENSITABS Product code Original Neo Sensitabs Product code CLSI potency Neo Sensitabs 80712 Ertapenem 10 µg 80712 Ertapenem 10 µg 80512N Imipenem+EDTA 80512N Imipenem+EDTA 75312 Meropenem 10 µg 4312 Meropenem 10 µg 7412 Imipenem 15 µg 1212 Imipenem 10 µg 70212 Amoxycillin + Clavulanate (30 + 15 µg) 0112 Amoxycillin + Clavulanate (20 + 10 µg) REFERENCES 1) Smith Moland E et al : Newer beta lactamases : Clinical and Laboratory implications.clin Microbiol Newsletter 30, 71 84,2008 2) Kyeong Seob Shin et al : Dipicolinic acid based disk methods for detection of metallo beta lactamase producing Pseudomonas spp and Acinetobacter spp. Diagn Microbiol Infect Dis,2,102 105,2008. 3) Soichiro Kimura et al : Evaluation of dipicolinic acid for detection of IMP or VIM type metallo beta lactamase producing P aeruginosa clinical isolates. Diagn Microbiol Infect Dis 53,241 244,2005 4) Pasteran FG et al : Klebsiella pneumoniae Carbapenemase 2,Buenos Aires,Argentina. Emerg Infect Dis 14, 1178 1180,2008. 5) Bradford PA et al: Emergence of carbapenem resistant Klebsiella spp possessing the class A carbapenem hydrolyzing KPC 2 and inhibitor resistant TEM 30 beta lactamases in New York City. Clin Infect Dis 39,55 0,2004. ) Poirel L et al : Carbapenem resistance in A. baumannii : mechanisms and epidemiology. Clin Microbiol Infect 12,82 83,200. 7) Yilmaz M et al : Warning! Oxacillinase mediated carbapenem resistance spreading in Enterobacteriaceae. Presentation P 1517, ECCMID 2008,Barcelona. 8) Cuzon G et al : Plasmid encoded carbapenem hydrolyzing beta lactamase OXA 48 in an Imipenem susceptible K. pneumoniae strain from Belgium. Antimicr Ag. Chemother. 52, 343 244,2008. 9) Tsakris A. et al: First occurence of KPC-possessing K. Pneumoniae in a Greek hospital and recommendation for detection with Boronic Acid disc tests. J.A.C. 2, 1257-120, 2008 10) Doi Y. et al: Simple disk-based method for detection of K. pneumonia carbapenemase-type beta lactamase by use of a Boronic Acid compound. J.C.M. 4, 4083-407, 2008. 11) Giske Chr. : Personal communication, 2009 Page